Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Vivanta Industries Limited has entered into certain business collaboration agreements with Qness Pharmaceuticals, a proprietorship concern in connection with the manufacture, supply, branding and marketing of pharmaceutical and allied products.
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-memorandum-of-understanding-agreements-14
View original source (BSE India)Vivanta Industries Ltd on 6ix
Story so far
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting Under Regulation 29(1)(A) And 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Nodal Officer Under IEPF (Accounting, Audit, Transfer And Refund) Rules, 2016.
Earlier from Vivanta Industries
- Vivanta Industries Ltd Press Release Jun 06 2026
- Clarification Regarding Non-Filing Of Annual Disclosure Of Large Corporate For FY 2025-2026
- Vivanta Industries Ltd Press Release Jun 05 2026
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
- Vivanta Industries Ltd Press Release May 30 2026
Later from Vivanta Industries
- Closure of Trading Window
- Vivanta Industries Ltd Press Release Jun 26 2026
- Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vivanta Industries Ltd Press Release Jul 01 2026
- Board Meeting Intimation for Financial Results For The Quarter Ended On 30Th June, 2026, Along With The Limited Review Report
Follow Vivanta Industries into a list and get an email when it puts out news.
Follow Vivanta Industries